Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury

Acute kidney injury (AKI) is common in patients with cirrhosis and associated with significant mortality. The most common etiologies of AKI in this setting are prerenal azotemia (PRA), acute tubular necrosis (ATN), and hepatorenal syndrome (HRS). Accurately distinguishing the etiology of AKI is critical, as treatments differ markedly. However, establishing an accurate differential diagnosis is extremely challenging. Urinary biomarkers of kidney injury distinguish structural from functional causes of AKI and may facilitate more accurate and rapid diagnoses. We conducted a multicenter, prospective cohort study of patients with cirrhosis and AKI assessing multiple biomarkers for differential diagnosis of clinically adjudicated AKI. Patients (n = 36) whose creatinine returned to within 25% of their baseline within 48 hours were diagnosed with PRA. In addition, 76 patients with progressive AKI were diagnosed by way of blinded retrospective adjudication. Of these progressors, 39 (53%) patients were diagnosed with ATN, 19 (26%) with PRA, and 16 (22%) with HRS. Median values for neutrophil gelatinase‐associated lipocalin (NGAL), interleukin‐18 (IL‐18), kidney injury molecule‐1 (KIM‐1), liver‐type fatty acid binding protein (L‐FABP), and albumin differed between etiologies and were significantly higher in patients adjudicated with ATN. The fractional excretion of sodium (FENa) was lowest in patients with HRS, 0.10%, but did not differ between those with PRA, 0.27%, or ATN, 0.31%, P = 0.54. The likelihood of being diagnosed with ATN increased step‐wise with the number of biomarkers above optimal diagnostic cutoffs. Conclusion: Urinary biomarkers of kidney injury are elevated in patients with cirrhosis and AKI due to ATN. Incorporating biomarkers into clinical decision making has the potential to more accurately guide treatment by establishing which patients have structural injury underlying their AKI. Further research is required to document biomarkers specific to HRS. (Hepatology 2014;60:622–632)

[1]  F. Durand,et al.  Acute Kidney Injury in Cirrhosis. , 2015, Critical care clinics.

[2]  A. Sanyal,et al.  Association of AKI With mortality and complications in hospitalized patients with cirrhosis , 2013, Hepatology.

[3]  M. Tsai,et al.  Acute renal failure in cirrhotic patients with severe sepsis: Value of urinary interleukin‐18 , 2013, Journal of gastroenterology and hepatology.

[4]  J. Friedewald,et al.  Outcomes and Native Renal Recovery Following Simultaneous Liver–Kidney Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  W. Jiménez,et al.  Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. , 2012, Journal of hepatology.

[6]  T. Nickolas,et al.  Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis , 2012, Digestive Diseases and Sciences.

[7]  W. Ye,et al.  Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  C. Edelstein,et al.  Clinical applications of biomarkers for acute kidney injury. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Jeffrey M. Turner,et al.  Acute kidney injury as a causal factor in mortality associated with hepatorenal syndrome , 2011, Hepatology international.

[10]  P. Tandon,et al.  Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  S. Navaneethan,et al.  Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis , 2011, International Urology and Nephrology.

[12]  R. Bellomo,et al.  Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis , 2011, Gut.

[13]  M. Rosner,et al.  Pretransplant predictors of recovery of renal function after liver transplantation , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  R. Schrier,et al.  Fluid administration in critically ill patients with acute kidney injury. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[15]  A. Go,et al.  Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. , 2010, Kidney international.

[16]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[17]  T. Gonwa,et al.  Kidney Allocation to Liver Transplant Candidates with Renal Failure of Undetermined Etiology: Role of Percutaneous Renal Biopsy , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  D. Gerber,et al.  Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK) , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  A. Gerbes,et al.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.

[20]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[21]  R. Selby,et al.  Comparison of Renal Allograft Outcomes in Combined Liver-Kidney Transplantation Versus Subsequent Kidney Transplantation in Liver Transplant Recipients: Analysis of UNOS Database , 2006, Transplantation.

[22]  Qing Ma,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.

[23]  C. Edelstein,et al.  Urinary interleukin-18 is a marker of human acute tubular necrosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[25]  V. Arroyo,et al.  Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short‐term prognosis , 2001, Hepatology.

[26]  M. Kurimoto,et al.  Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy. , 2000, Cytokine.

[27]  P. MacEneaney,et al.  The meaning of diagnostic test results: a spreadsheet for swift data analysis. , 2000, Clinical radiology.

[28]  Sarah C. Emerson,et al.  Imperfect gold standards for kidney injury biomarker evaluation. , 2012, Journal of the American Society of Nephrology : JASN.

[29]  V. Arroyo,et al.  Pathophysiological basis of albumin use in cirrhosis. , 2011, Annals of hepatology.